Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Microbiota"" wg kryterium: Temat


Tytuł :
The gut microbiota and gut disease.
Autorzy :
Fehily SR; Department of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Basnayake C; Department of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Wright EK; Department of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Kamm MA; Department of Gastroenterology, St Vincent's Hospital, Melbourne, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
Pokaż więcej
Źródło :
Internal medicine journal [Intern Med J] 2021 Oct; Vol. 51 (10), pp. 1594-1604.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Clostridioides difficile*
Gastrointestinal Microbiome*
Inflammatory Bowel Diseases*/therapy
Microbiota*
Probiotics*/therapeutic use
Fecal Microbiota Transplantation ; Humans
Czasopismo naukowe
Tytuł :
RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients' Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections.
Autorzy :
Khanna S; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Pardi DS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Jones C; Rebiotix Inc, a Ferring Company, Roseville, Minnesota, USA.
Shannon WD; BioRankings LLC, St. Louis, Missouri, USA.
Gonzalez C; BioRankings LLC, St. Louis, Missouri, USA.
Blount K; Rebiotix Inc, a Ferring Company, Roseville, Minnesota, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Oct 05; Vol. 73 (7), pp. e1613-e1620.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Clostridioides difficile*
Clostridium Infections*/drug therapy
Microbiota*
Adult ; Clostridioides ; Fecal Microbiota Transplantation ; Humans ; Recurrence ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment.
Autorzy :
Drekonja DM; Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, USA.
Shaukat A; Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, USA.
Zhang JH; Veterans Affairs Cooperative Studies Program Coordinating Center, Veterans Affairs Connecticut Health Care System, West Haven, CT, USA.
Reinink AR; Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, USA.
Nugent S; Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, USA.
Dominitz JA; Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
Davis-Karim A; Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, USA.
Gerding DN; Edward Hines, Jr. Veterans Affairs Hospital, Hines, IL, USA.
Kyriakides TC; Veterans Affairs Cooperative Studies Program Coordinating Center, Veterans Affairs Connecticut Health Care System, West Haven, CT, USA.
Pokaż więcej
Źródło :
Clinical trials (London, England) [Clin Trials] 2021 Oct; Vol. 18 (5), pp. 622-629. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Anti-Bacterial Agents*/therapeutic use
Clostridioides difficile*
Fecal Microbiota Transplantation*
Clostridium Infections/*therapy
COVID-19 ; Humans ; Microbiota ; Quality of Life ; Recurrence ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review.
Autorzy :
Gu X; Department of Human Anatomy, Shandong First Medical University and Shandong Academy of Medical Sciences, Taian, China.
Lu Q; Department of Prescription Science, School of Basic Medical Sciences, Hebei University of Chinese Medicine, Shijiazhuang, China.
Zhang C; Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Tang Z; Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Chu L; Institute of Child Development and Education, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, China.
Pokaż więcej
Źródło :
Seminars in liver disease [Semin Liver Dis] 2021 Nov; Vol. 41 (4), pp. 495-506. Date of Electronic Publication: 2021 Jul 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Gastrointestinal Microbiome*
Microbiota*
Fecal Microbiota Transplantation ; Feces ; Humans ; Liver Cirrhosis
Czasopismo naukowe
Tytuł :
Gut microbiota and sepsis: from pathogenesis to novel treatments.
Autorzy :
Kullberg RFJ; Center for Experimental and Molecular Medicine (CEMM).; Microbiota Center Amsterdam.
Wiersinga WJ; Center for Experimental and Molecular Medicine (CEMM).; Microbiota Center Amsterdam.; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers - Location AMC, University of Amsterdam, Amsterdam, The Netherlands.
Haak BW; Center for Experimental and Molecular Medicine (CEMM).; Microbiota Center Amsterdam.
Pokaż więcej
Źródło :
Current opinion in gastroenterology [Curr Opin Gastroenterol] 2021 Nov 01; Vol. 37 (6), pp. 578-585.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Gastrointestinal Microbiome*
Microbiota*
Probiotics*/therapeutic use
Sepsis*/therapy
Dysbiosis ; Fecal Microbiota Transplantation ; Humans
Czasopismo naukowe
Tytuł :
Exploring the microbiota-Alzheimer's disease linkage using short-term antibiotic treatment followed by fecal microbiota transplantation.
Autorzy :
Wang M; School of Food Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, China.
Cao J; School of Food Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, China.
Gong C; School of Food Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, China.
Amakye WK; School of Food Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, China.
Yao M; State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510182, China.
Ren J; School of Food Science and Engineering, South China University of Technology, Guangzhou, Guangdong 510641, China; Sino-Singapore International Joint Research Institute, Guangzhou Knowledge City, Guangzhou, Guangdong 510555, China. Electronic address: .
Pokaż więcej
Źródło :
Brain, behavior, and immunity [Brain Behav Immun] 2021 Aug; Vol. 96, pp. 227-238. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Alzheimer Disease*/therapy
Microbiota*
Amyloid beta-Peptides ; Animals ; Anti-Bacterial Agents ; Disease Models, Animal ; Fecal Microbiota Transplantation ; Mice ; Mice, Transgenic
Czasopismo naukowe
Tytuł :
Microbiomes in the Intestine of Developing Pigs: Implications for Nutrition and Health.
Autorzy :
Mu C; Laboratory of Gastrointestinal Microbiology, Jiangsu Key Laboratory of Gastrointestinal Nutrition and Animal Health, College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China.; National Center for International Research On Animal Gut Nutrition, Nanjing Agricultural University, Nanjing, 210095, China.
Pi Y; Laboratory of Gastrointestinal Microbiology, Jiangsu Key Laboratory of Gastrointestinal Nutrition and Animal Health, College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China.; National Center for International Research On Animal Gut Nutrition, Nanjing Agricultural University, Nanjing, 210095, China.
Zhang C; Laboratory of Gastrointestinal Microbiology, Jiangsu Key Laboratory of Gastrointestinal Nutrition and Animal Health, College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China.; National Center for International Research On Animal Gut Nutrition, Nanjing Agricultural University, Nanjing, 210095, China.
Zhu W; Laboratory of Gastrointestinal Microbiology, Jiangsu Key Laboratory of Gastrointestinal Nutrition and Animal Health, College of Animal Science and Technology, Nanjing Agricultural University, Nanjing, 210095, China. .; National Center for International Research On Animal Gut Nutrition, Nanjing Agricultural University, Nanjing, 210095, China. .
Pokaż więcej
Źródło :
Advances in experimental medicine and biology [Adv Exp Med Biol] 2022; Vol. 1354, pp. 161-176.
Typ publikacji :
Journal Article
MeSH Terms :
Gastrointestinal Microbiome*
Microbiota*
Animals ; Fecal Microbiota Transplantation ; Feces ; Intestines ; Swine
Czasopismo naukowe
Tytuł :
Microbiota and viral hepatitis: State of the art of a complex matter.
Autorzy :
Milosevic I; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia Faculty of Medicine, University of Belgrade, Belgrade 101801, Serbia. .
Russo E; Department of Experimental and Clinical Medicine, University of Florence, Firenze 50100, Italy.
Vujovic A; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia Faculty of Medicine, University of Belgrade, Belgrade 101801, Serbia.
Barac A; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia Faculty of Medicine, University of Belgrade, Belgrade 101801, Serbia.
Stevanovic O; Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia Faculty of Medicine, University of Belgrade, Belgrade 101801, Serbia.
Gitto S; Department of Experimental and Clinical Medicine, University of Florence, Firenze 50100, Italy.
Amedei A; Department of Experimental and Clinical Medicine, University of Florence, Firenze 50100, Italy.
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2021 Sep 07; Vol. 27 (33), pp. 5488-5501.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Gastrointestinal Microbiome*
Hepatitis, Viral, Human*
Microbiota*
Dysbiosis ; Fecal Microbiota Transplantation ; Humans
Czasopismo naukowe
Tytuł :
Microbiota and epigenetics: promising therapeutic approaches?
Autorzy :
El-Sayed A; Department of Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
Aleya L; Chrono-Environnement Laboratory, UMR CNRS 6249, Bourgogne Franche-Comté University, F-25030, Besançon Cedex, France.
Kamel M; Department of Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt. .
Pokaż więcej
Źródło :
Environmental science and pollution research international [Environ Sci Pollut Res Int] 2021 Sep; Vol. 28 (36), pp. 49343-49361. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Microbiota*
Probiotics*
Synbiotics*
Fecal Microbiota Transplantation ; Prebiotics
Czasopismo naukowe
Tytuł :
Combination therapy of curcumin and fecal microbiota transplant: Potential treatment of polycystic ovarian syndrome.
Autorzy :
Corrie L; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India.
Gulati M; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India. Electronic address: .
Vishwas S; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India.
Kapoor B; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India.
Singh SK; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India.
Awasthi A; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India.
Khursheed R; School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, India.
Pokaż więcej
Źródło :
Medical hypotheses [Med Hypotheses] 2021 Sep; Vol. 154, pp. 110644. Date of Electronic Publication: 2021 Jul 15.
Typ publikacji :
Journal Article
MeSH Terms :
Curcumin*/therapeutic use
Microbiota*
Polycystic Ovary Syndrome*/therapy
Dysbiosis/therapy ; Fecal Microbiota Transplantation ; Female ; Humans
Czasopismo naukowe
Tytuł :
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia.
Autorzy :
Jia X; College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.; Centre of Biomedical Research & Development, Fujian University of Traditional Chinese Medicine, Fuzhou, China.; The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
Xu W; College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.; Centre of Biomedical Research & Development, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
Zhang L; Shanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Li X; College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.; Centre of Biomedical Research & Development, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
Wang R; Shanghai Innovation Center of TCM Health Service, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Wu S; College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.; Centre of Biomedical Research & Development, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
Pokaż więcej
Źródło :
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2021 Aug 19; Vol. 11, pp. 634780. Date of Electronic Publication: 2021 Aug 19 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Gastrointestinal Microbiome*
Hyperlipidemias*
Metabolic Diseases*
Microbiota*
Animals ; Fecal Microbiota Transplantation ; Mice
Czasopismo naukowe
Tytuł :
Management of Severe and Severe/Complicated Clostridoides difficile Infection Using Sequential Fecal Microbiota Transplant by Retention Enema.
Autorzy :
Rupawala AH; Division of Gastroenterology, Department of Internal Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Gachette D; Department of Internal Medicine, NYU Langone Medical Center, New York, New York, USA.
Bakhit M; Division of Gastroenterology, Lahey Clinic, Burlington, Massachusetts, USA.
Jimoh L; Carolina Digestive, Charlotte, North Carolina, USA.
Kelly CR; Division of Gastroenterology, Department of Internal Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Aug 16; Vol. 73 (4), pp. 716-719.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Clostridioides difficile*
Clostridium Infections*/therapy
Microbiota*
Enema ; Fecal Microbiota Transplantation ; Feces ; Humans ; Recurrence ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Fecal Microbiota Transplant for Severe Clostridioides Difficile Infection: Let's Halt the Raging Fire.
Autorzy :
McGill SK; Chapel Hill School of Medicine, University of North Carolina-Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Aug 16; Vol. 73 (4), pp. 720-721.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Clostridium Infections*/therapy
Microbiota*
Clostridioides ; Fecal Microbiota Transplantation ; Humans
Opinia redakcyjna
Tytuł :
Evolution of intestinal microbiome in a process of faecal microbiota transfer (FMT) in a patient with Clostridioides difficile infection: NGS analysis with different software programs.
Autorzy :
Ventero MP; Servicio de Microbiología. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante-ISABIAL, Alicante, España. Electronic address: .
Espinosa N; Servicio de Microbiología. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante-ISABIAL, Alicante, España.
Jover R; Servicio Digestivo. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante-ISABIAL, Alicante, España.
Guillen Y; Universidad Oberta de Catalunya, Barcelona, España.
Merino E; Unidad de Enfermedades infecciosas. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante-ISABIAL, Alicante, España.
Rodríguez JC; Servicio de Microbiología. Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante-ISABIAL, Alicante, España; Departamento de Producción Vegetal y Microbiología. Universidad Miguel Hernández de Elche (Alicante), Elche, España.
Pokaż więcej
Transliterated Title :
Evolución del microbioma intestinal en un proceso de transferencia de microbiota fecal (TMF) en un paciente con infección por Clostridioides difficile: análisis por NGS con diferentes programas bioinformáticos.
Źródło :
Enfermedades infecciosas y microbiologia clinica (English ed.) [Enferm Infecc Microbiol Clin (Engl Ed)] 2021 Apr; Vol. 39 (4), pp. 184-187. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji :
Journal Article
MeSH Terms :
Clostridioides difficile*
Gastrointestinal Microbiome*
Microbiota*
Clostridioides ; Fecal Microbiota Transplantation ; Humans ; Software
Czasopismo naukowe
Tytuł :
Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Autorzy :
Nishida A; Department of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 5268580, Shiga, Japan. .
Nishino K; Department of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 5268580, Shiga, Japan.
Sakai K; Department of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 5268580, Shiga, Japan.
Owaki Y; Department of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 5268580, Shiga, Japan.
Noda Y; Department of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 5268580, Shiga, Japan.
Imaeda H; Department of Gastroenterology and Hepatology, Nagahama City Hospital, Nagahama 5268580, Shiga, Japan.
Pokaż więcej
Źródło :
World journal of gastroenterology [World J Gastroenterol] 2021 Jun 21; Vol. 27 (23), pp. 3317-3326.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Gastrointestinal Microbiome*
Inflammatory Bowel Diseases*/therapy
Microbiota*
Dysbiosis ; Fecal Microbiota Transplantation ; Humans
Czasopismo naukowe
Tytuł :
The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial Resistance.
Autorzy :
Ranallo RT; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
McDonald LC; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Halpin AL; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Hiltke T; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Young VB; Department of Internal Medicine, Division of Infectious Diseases, The University of Michigan Medical School, Ann Arbor, Michigan, USA.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2021 Jun 16; Vol. 223 (12 Suppl 2), pp. S187-S193.
Typ publikacji :
Introductory Journal Article
MeSH Terms :
Drug Resistance, Microbial*
Microbiota*/drug effects
Communicable Diseases/*microbiology
Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Antimicrobial Stewardship ; Communicable Diseases/diagnosis ; Communicable Diseases/immunology ; Communicable Diseases/therapy ; Fecal Microbiota Transplantation ; Homeostasis ; Host-Pathogen Interactions ; Humans ; Immunity
Czasopismo naukowe
Tytuł :
How to Apply FMT More Effectively, Conveniently and Flexible - A Comparison of FMT Methods.
Autorzy :
Varga A; Department of Medical Microbiology and Immunology, University of Pécs Clinical Centre, Pécs, Hungary.
Kocsis B; Department of Medical Microbiology and Immunology, University of Pécs Clinical Centre, Pécs, Hungary.
Sipos D; 1stDepartment of Internal Medicine - Department of Infectology, University of Pécs Clinical Centre, Pécs, Hungary.
Kása P; Institute of Pharmaceutical Technology and Biopharmacy, University of Pécs Faculty of Pharmacy, Pécs, Hungary.
Vigvári S; 1stDepartment of Internal Medicine - Department of Infectology, University of Pécs Clinical Centre, Pécs, Hungary.
Pál S; Institute of Pharmaceutical Technology and Biopharmacy, University of Pécs Faculty of Pharmacy, Pécs, Hungary.
Dembrovszky F; Institute for Translational Medicine, University of Pécs Medical School, Pécs, Hungary.
Farkas K; Institute of Bioanalysis, University of Pécs Medical School, Pécs, Hungary.
Péterfi Z; 1stDepartment of Internal Medicine - Department of Infectology, University of Pécs Clinical Centre, Pécs, Hungary.
Pokaż więcej
Źródło :
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2021 Jun 04; Vol. 11, pp. 657320. Date of Electronic Publication: 2021 Jun 04 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Clostridioides difficile*
Clostridium Infections*
Microbiota*
Fecal Microbiota Transplantation ; Humans ; Recurrence ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant.
Autorzy :
Zellmer C; OpenBiome, Cambridge, Massachusetts, USA.
Sater MRA; Day Zero Diagnostics, Allston, Massachusetts, USA.
Huntley MH; Day Zero Diagnostics, Allston, Massachusetts, USA.
Osman M; OpenBiome, Cambridge, Massachusetts, USA.
Olesen SW; OpenBiome, Cambridge, Massachusetts, USA.
Ramakrishna B; OpenBiome, Cambridge, Massachusetts, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jun 01; Vol. 72 (11), pp. e876-e880.
Typ publikacji :
Journal Article
MeSH Terms :
Clostridioides difficile*
Clostridium Infections*
Escherichia coli Infections*
Microbiota*
Shiga-Toxigenic Escherichia coli*
Fecal Microbiota Transplantation ; Feces ; Humans
Czasopismo naukowe
Tytuł :
Fecal microbiota transplantation in hepatic encephalopathy: a systematic review.
Autorzy :
Madsen M; Gastro Unit, Medical Division, Hvidovre University Hospital, Copenhagen, Denmark.
Kimer N; Gastro Unit, Medical Division, Hvidovre University Hospital, Copenhagen, Denmark.; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Bendtsen F; Gastro Unit, Medical Division, Hvidovre University Hospital, Copenhagen, Denmark.
Petersen AM; Gastro Unit, Medical Division, Hvidovre University Hospital, Copenhagen, Denmark.; Department of Clinical Microbiology, Hvidovre University Hospital, Copenhagen, Denmark.
Pokaż więcej
Źródło :
Scandinavian journal of gastroenterology [Scand J Gastroenterol] 2021 May; Vol. 56 (5), pp. 560-569. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Gastrointestinal Microbiome*
Hepatic Encephalopathy*/therapy
Microbiota*
Ammonia ; Fecal Microbiota Transplantation ; Feces ; Humans ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies